5 Reasons This Will Be Zimmer Biomet’s Comeback Year

May 1, 2019 Business, Medical Devices, Medical Technology, Orthopedics, Zimmer Biomet

Zimmer Biomet’s revenue growth is expected to accelerate during 2019 as the company shifts back to offense after addressing supply issues that have plagued the orthopedic device maker since 2016.

The company was dealing with complex challenges that involved quality control and supply chain problems that began a year earlier, which created distrust among the sales organization for corporate, and a culture gap between the “Zimmer camp” and “Biomet camp.”

But Hanson quickly identified several short-term priorities that Zimmer Biomet (ZB) has been working toward for the past 15 months and it appears that 2019 will be Zimmer Biomet’s comeback year. Here are five reasons why.

1. Shifting from Supply Stability to Supply Efficiency

During Zimmer Biomet’s first-quarter earnings call, Hanson said the company is shifting its focus from supply stability to initiatives aimed at increasing the overall supply chain efficiency.

“We see continued progress in our ability to regain the full trust of our commercial organization as we move to offense and focus on winning new business,” he said, according to SeekingAlpha transcripts of the call.

Boosting confidence in the supply chain, the company is planning new product launches in the knee implant market later this year along with the launch of knee, spine, and brain applications for its Rosa robotic system.

“Relative to new products, 2019 will be an important year for Zimmer Biomet’s pipeline and commercial strategy,” Hanson said.

In March, the company showcased its latest products and offered a preview of its next-generation solutions at the annual meeting of the American Academy of Orthopaedic Surgeons (AAOS).

By Amanda Pedersen | MD+DI

Image Credit: Zimmer Biomet

READ MORE

About Peter Coffaro 510 Articles

Peter Coffaro is a growth-driven and strategic executive with over 25 years of progressive management success in the medical device industry. With a proven track record and recognized expertise, Peter has established himself as one of the top influencers in medical sales, as acknowledged by prestigious publications such as the World Journal of Orthopedics, Exponential Healthtech, and MedReps.com. Throughout his career, Peter has accumulated 10 years of combined sales management experience, excelling in various roles including Director, General Manager, Distributor, and Vice President. He has worked for industry-leading orthopedic companies such as Zimmer, DePuy, and Stryker, solidifying his deep knowledge and network within the field. Peter’s passion for innovation and emerging technologies led him to found OrthoFeed, an award-winning blog covering digital orthopedic news and emerging medical technologies. Through this platform, he stays at the forefront of the industry and contributes to the dissemination of valuable insights. Peter is a three-time Hall of Fame award winner at Johnson and Johnson, demonstrating his exceptional contributions and impact on the organization. His expertise extends to areas such as organizational development, business development, sales management, digital marketing, and professional education. Peter earned a B.S. degree in Biology and Chemistry from Northern Illinois University, further complementing his comprehensive understanding of the medical field. With his wealth of experience, strategic mindset, and dedication to advancing healthcare, Peter Coffaro is a valuable asset and leader in the medical device industry.